GLP-1 RA use is associated with a 38% to 42% lower risk for hepatic complications, including cirrhosis, among those with MASLD and T2D.
Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic ...
The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most ...
A study led by scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) has uncovered how the gut microbiome can influence gene activity in the liver by acting on short stretches of ...
An athlete and nursing student was rushed into surgery after doctors thought she had appendicitis. But during surgery, they ...
There is a new awareness of the widespread nature of metabolic dysfunction–associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed ...
Think surgery automatically means spending days in hospital? Not always. Doctors explain how modern techniques are making day ...
dIICB-Translational Research Unit of Excellence, Department of Cancer Biology and Inflammatory Disorders, CSIR-Indian Institute of Chemical Biology, Kolkata, West Bengal, 700091, India eDivision of ...
A 20-year-old nursing student checked into hospital with a kidney stone and woke up weeks later with no memory – and a new liver. But that’s what happened when Gemma Mackay developed severe sepsis and ...
A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...
A new drug that targets a gene behind pancreatic cancer has physicians and researchers cautiously optimistic about improved treatment for one of the deadliest cancers. Researchers found that a new ...
A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer. The drug, called daraxonrasib, appears to be a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results